Skip to Main Content
Skip Nav Destination

Instructions for Authors

Updated February 1, 2024

The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials. All submissions to Clinical Diabetes will be reviewed by the editorial team and considered for publication if they contain information that would be helpful to the journal’s readership. All articles, whether invited or submitted, should be written with general practice, family practice, or internal medicine providers in mind as the main audience.

Manuscript Submission and Peer Review

Manuscripts may be submitted via Before submitting an article, please review the information below and click on the appropriate link for further instructions related to the content and format of the article you wish to submit. The corresponding author should complete, sign, and return the manuscript submission form on behalf of all authors at the time of or soon after submitting an article. Once a manuscript is submitted, the review process generally takes 4–6 weeks. Failure to follow the manuscript preparation and submission instructions may delay the review process.

Article Types

Feature Articles
Feature articles present either original research or reviews of topics related to diabetes in primary practice. 

Standing departments in Clinical Diabetes include:

For detailed instructions on writing these various types of articles, visit the Detailed Information for Authors page.


Editorial Policies

ADA’s Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for Clinical Diabetes have been adopted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of Clinical Diabetes. Comprehensive information related to the editorial and ethical policies of Clinical Diabetes can be found in Publication Policies and Procedures for ADA Journals. The Association's Publications Policy Committee or Subcommittee on Ethical Scientific Publications will consider on a case-by-case basis policies that are not addressed in the policies document, which contains information related to the following topics:

  • Study Design
  • Originality and Prior Publication
  • Authorship and Contributions
  • Acknowledgments
  • Conflict of Interest
  • Data Access and Responsibility
  • Clinical Trials, Systematic Reviews, and Meta-Analyses
  • Plagiarism
  • Digital Image Manipulation
  • Responses to Possible Scientific Misconduct
  • Peer Review
  • Editorial Decisions
  • Prepublication of Accepted Articles
  • Reuse, Post-Prints, and Public Access
  • Errata
  • Media Embargoes
  • Advertising
  • Supplements 

Frequently referenced sections appear below. The complete document is available at: 

Accepted Manuscripts

To make new research readily available to subscribers, Clinical Diabetes publishes original research articles online ahead of print.

The designated corresponding author will receive notification of availability of page proofs by email. Corrections should be returned promptly upon receipt of the proof. Failure to do so may delay the publication of the article.

ADA partners with Kudos, a platform designed to help authors engage broad audiences with their work, while tracking usage and reach. The Kudos service is integrated with ADA’s peer-review system, where plain language summaries are captured for sharing, and authors are invited to access a comprehensive overview of their article usage, altmetric, and other behavioral data in a dashboard view. Upon acceptance, authors will receive an email invitation to register and view their dashboard and promote and track their article.

Financial Obligations for Accepted Manuscripts

Article-processing charges are assessed for non-invited articles to help defray the costs related to the peer review, editorial production and publication, access and dissemination, and archiving and indexing of articles published in Clinical Diabetes.

For articles submitted on or after February 1, 2024, article processing charges will be assessed at $175 per typeset journal page.

In addition, Clinical Diabetes offers an “Open Choice” option for authors who wish to make their published article immediately accessible to nonsubscribers. By paying an additional article-processing charge of $250 per page, authors may elect to have their articles freely available on the journal's website immediately upon publication online. Upon receipt of payment and on behalf of the author, ADA will also deposit the final version of the published paper into PubMed Central. 

Authors will receive an invoice for publication fees, as well as a reprint order form, when page proofs become available. Unless otherwise indicated, it is assumed that the corresponding author takes responsibility for payment. Questions regarding billing or payment should be directed to

ADA recognizes that authors, their institutions, or their funding bodies, particularly those from low-income countries, may be unable to meet these financial obligations. In such cases, authors should submit requests for discounts or waivers of article-processing charges via the following online form: Publication Fee Request.

It should be noted that payment of publication fees or waiver status does not in any way influence the editorial decision-making process or the publication of any paper submitted to ADA journals.

Supplemental Material

Nonessential tables, figures, and/or videos may accompany articles as online-only supplemental material files, but authors are asked to include a comment to the editor at the time of manuscript submission that explains the rationale and justification for submitting and possibly posting the supplemental information.

All online-only supplemental material files should be uploaded during the submission process. The file must be clearly labeled as "Online-Only Supplemental Material." In addition, supplemental material online-only files must be referenced in the main text of the manuscript at least once (e.g., Supplemental Table S1).

All online-only supplemental material files are subject to peer review but will not be composed, copyedited, or proofread by production staff. As such, authors are encouraged to review supplemental material files carefully before submission.  

Supplemental material containing very large datasets should be cited in the text with a URL to the material hosted on an author-affiliated website or data repository or may appear with a note that the data is available upon request to the author.

ADA partners with Figshare to publish supplemental material online. All supplemental material files accepted for publication with the manuscript will be uploaded to Figshare by ADA production staff and linked to the article on Clinical Diabetes. View and search all supplemental materials for Clinical Diabetes on Figshare at

ADA Professional Publications Personnel and Contacts

ADA professional publications include books, clinical compendia, scholarly journals, professional news, podcasts, and multimedia. Contact Us With Questions.

Peer Review Office

American Diabetes Association
Editorial Office
9702 East Washington Street
Suite 400, #356
Indianapolis, IN 46229
Phone: (317) 354-1508, ext. 1782
Fax: (317) 547-4656

Close Modal

or Create an Account

Close Modal
Close Modal